rhodioloside has been researched along with Cancer of Skin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, YH; Xu, SP | 1 |
| Furmanowa, M; Malinowski, M; Mazurkiewicz, M; Siwicki, AK; Skopińska-Rózewska, E; Sommer, E; Wasiutyński, A | 1 |
2 other study(ies) available for rhodioloside and Cancer of Skin
| Article | Year |
|---|---|
Salidroside prevents skin carcinogenesis induced by DMBA/TPA in a mouse model through suppression of inflammation and promotion of apoptosis.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Survival; Cytokines; Drug Administration Schedule; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Mice; Phenols; Random Allocation; Skin Neoplasms; Tetradecanoylphorbol Acetate; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2018 |
The influence of Rhodiola quadrifida 50% hydro-alcoholic extract and salidroside on tumor-induced angiogenesis in mice.
Topics: Animals; Dose-Response Relationship, Drug; Female; Glucosides; Mice; Mice, Inbred BALB C; Neovascularization, Pathologic; Phenols; Phytotherapy; Plant Extracts; Random Allocation; Rhodiola; Skin Neoplasms | 2008 |